Saraswati Heart Care And Research Centre Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 03-01-2025
- Paid Up Capital ₹ 2.50 M
as on 03-01-2025
- Company Age 18 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.00 Cr
as on 03-01-2025
- Revenue 7.40%
(FY 2022)
- Profit 15.06%
(FY 2022)
- Ebitda 7.39%
(FY 2022)
- Net Worth 18.93%
(FY 2022)
- Total Assets 19.04%
(FY 2022)
About Saraswati Heart Care And Research Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company has closed loans amounting to ₹1.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Vandana Agrawal and Dinesh Agrawal serve as directors at the Company.
- CIN/LLPIN
U85110UP2006PTC031572
- Company No.
031572
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Mar 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Allahabad, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Saraswati Heart Care And Research Centre?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dinesh Agrawal  | Managing Director | 01-Apr-2011 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vandana Agrawal | Director | 31-Mar-2006 | Current |
Financial Performance of Saraswati Heart Care And Research Centre.
Saraswati Heart Care And Research Centre Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 7.4% increase. The company also saw a substantial improvement in profitability, with a 15.06% increase in profit. The company's net worth Soared by an impressive increase of 18.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Saraswati Heart Care And Research Centre?
In 2019, Saraswati Heart Care And Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Union Bank Of India Creation Date: 14 Mar 2007 | ₹1.00 Cr | Satisfied |
How Many Employees Work at Saraswati Heart Care And Research Centre?
Unlock and access historical data on people associated with Saraswati Heart Care And Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Saraswati Heart Care And Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saraswati Heart Care And Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
